{"id":"amoxicillin-and-metronidazole","safety":{"commonSideEffects":[{"rate":"5-15","effect":"Diarrhea"},{"rate":"3-10","effect":"Nausea"},{"rate":"2-8","effect":"Abdominal pain"},{"rate":"5-10","effect":"Metallic taste (metronidazole)"},{"rate":"1-3","effect":"Allergic reaction (amoxicillin)"},{"rate":"2-5","effect":"Headache"}]},"_chembl":{"chemblId":"CHEMBL2105950","moleculeType":"Small molecule","molecularWeight":"387.39"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Amoxicillin is a beta-lactam antibiotic that binds to penicillin-binding proteins and inhibits peptidoglycan cross-linking in bacterial cell walls, leading to cell lysis. Metronidazole is a nitroimidazole that generates reactive intermediates in anaerobic organisms, causing DNA strand breaks and cell death. Together, they provide synergistic coverage for mixed aerobic-anaerobic infections.","oneSentence":"This combination uses amoxicillin to inhibit bacterial cell wall synthesis and metronidazole to disrupt anaerobic bacterial DNA, providing broad-spectrum coverage against aerobic and anaerobic pathogens.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:21:42.362Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Mixed aerobic-anaerobic bacterial infections"},{"name":"Helicobacter pylori eradication (as part of triple or quadruple therapy)"},{"name":"Periodontal infections"},{"name":"Intra-abdominal infections"}]},"trialDetails":[{"nctId":"NCT00713947","phase":"PHASE4","title":"Effectiveness of the Eradication of Helicobacter Pylori and an Inhibitor of Pump With Proton Versus Control","status":"WITHDRAWN","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2008-04","conditions":"Positive Helicobacter Pylori Serology, Coronary Thrombosis, Supra-aortic Artery Thrombosis","enrollment":""},{"nctId":"NCT07455448","phase":"","title":"Antibiotic Resistance of Helicobacter Pylori in Nanjing: A Cross-Sectional Study","status":"NOT_YET_RECRUITING","sponsor":"Nanjing First Hospital, Nanjing Medical University","startDate":"2026-03","conditions":"HELICOBACTER PYLORI INFECTIONS","enrollment":7228},{"nctId":"NCT07451171","phase":"PHASE2","title":"Comparative Efficacy of Antibiotics for Small Intestine Bacterial Overgrowth in Bangladeshi Children","status":"NOT_YET_RECRUITING","sponsor":"University of Virginia","startDate":"2026-04","conditions":"Small Intestine Bacterial Overgrowth","enrollment":60},{"nctId":"NCT06156085","phase":"PHASE4","title":"Fourteen-Day Vonoprazan-Based Dual Therapy With Amoxicillin as First-Line Helicobacter Pylori Treatment in Comparison With Extended Sequential Therapy","status":"COMPLETED","sponsor":"Fu Jen Catholic University Hospital","startDate":"2023-11-14","conditions":"Helicobacter Pylori Infection","enrollment":337},{"nctId":"NCT07405684","phase":"PHASE4","title":"Fecal Molecular Susceptibility-guided Hp First-line Therapy","status":"NOT_YET_RECRUITING","sponsor":"Shanghai Zhongshan Hospital","startDate":"2026-02-28","conditions":"HELICOBACTER PYLORI INFECTIONS","enrollment":544},{"nctId":"NCT07405697","phase":"PHASE4","title":"Fecal Molecular Susceptibility-guided Hp Rescue Therapy","status":"NOT_YET_RECRUITING","sponsor":"Shanghai Zhongshan Hospital","startDate":"2026-02-28","conditions":"Helicobacter Pylori Infection","enrollment":290},{"nctId":"NCT06396078","phase":"PHASE4","title":"Improvement of PPROM Management With Prophylactic Antimicrobial Therapy (iPROMPT)","status":"RECRUITING","sponsor":"Ohio State University","startDate":"2024-07-18","conditions":"Preterm Premature Rupture of Membrane, Pregnancy, High Risk, Preterm Birth","enrollment":56},{"nctId":"NCT07010744","phase":"NA","title":"Effect of Triple Versus Quadruple Therapy for Treating Helicobacter Pylori Infection","status":"ENROLLING_BY_INVITATION","sponsor":"Akil Al Islam","startDate":"2025-07-01","conditions":"Dyspepsia","enrollment":66},{"nctId":"NCT07358130","phase":"NA","title":"Efficacies of Bismuth-amoxicillin-vonoprazan Triple Therapy and Bismuth Quadruple Therapy","status":"RECRUITING","sponsor":"Kaohsiung Medical University","startDate":"2025-10-21","conditions":"Helicobacter Pylori Infection","enrollment":552},{"nctId":"NCT04549311","phase":"PHASE3","title":"Perianal Abscess Recurrence and Fistula Formation: Antibiotics Following Incision and Drainage Trial","status":"COMPLETED","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2021-11-18","conditions":"Perianal Abscess, Perianal Fistula","enrollment":15},{"nctId":"NCT07312721","phase":"PHASE4","title":"Comparative Effectiveness of Triple Versus Quadruple Therapy in the Treatment of Helicobacter Pylori Induced Gastritis","status":"COMPLETED","sponsor":"Azfar Farogh","startDate":"2024-01-05","conditions":"Helicobacter Pylori Infection, Chronic Gastritis, Peptic Ulcer Disease","enrollment":752},{"nctId":"NCT07304882","phase":"PHASE3","title":"A Comparison of Recovery After Impacted Wisdom Tooth Removal","status":"COMPLETED","sponsor":"University of Science and Technology, Yemen","startDate":"2023-11-30","conditions":"Impacted Mandibular Third Molar Extraction, Post Operative Complications","enrollment":24},{"nctId":"NCT07104318","phase":"PHASE3","title":"Personalized vs Standard of Care Treatment for Helicobacter Pylori Eradication Among Veterans","status":"NOT_YET_RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2026-04-01","conditions":"Helicobacter Pylori","enrollment":360},{"nctId":"NCT05926804","phase":"NA","title":"A \"Screen and Treat\" Helicobacter Pylori Eradication Trial in Adolescents in Three Regions of Chile","status":"RECRUITING","sponsor":"Miguel O'Ryan Gallardo","startDate":"2022-08-02","conditions":"Helicobacter Pylori Infection","enrollment":500},{"nctId":"NCT05206500","phase":"PHASE4","title":"NextGen - Clinical Implication of Next Generation Sequencing","status":"RECRUITING","sponsor":"Wake Forest University Health Sciences","startDate":"2022-05-17","conditions":"Urinary Tract Infections","enrollment":100},{"nctId":"NCT07260006","phase":"NA","title":"Treatment Efficacy of Regimens With and Without Bismuth in Children With Helicobacter Pylori-Associated Peptic Ulcer Disease","status":"RECRUITING","sponsor":"Can Tho University of Medicine and Pharmacy","startDate":"2024-10-01","conditions":"Helicobacter Pylori Infection, Peptic Ulcer","enrollment":80},{"nctId":"NCT06126731","phase":"PHASE1, PHASE2","title":"Combination Study of Antibiotics With Enzalutamide (PROMIZE)","status":"RECRUITING","sponsor":"Institute of Cancer Research, United Kingdom","startDate":"2023-11-02","conditions":"Metastatic Castration-Resistant Prostate Cancer (mCRPC)","enrollment":39},{"nctId":"NCT05332444","phase":"PHASE4","title":"Efficacies of Susceptibility-guided vs Empiric Therapy for Rescue Treatment of Helicobacter Pylori Infection","status":"RECRUITING","sponsor":"National Taiwan University Hospital","startDate":"2022-04-11","conditions":"Helicobacter Pylori Infection","enrollment":450},{"nctId":"NCT03431688","phase":"NA","title":"Tailored Therapy for Clarithromycin-Resistant H. Pylori","status":"COMPLETED","sponsor":"Kangdong Sacred Heart Hospital","startDate":"2018-10-01","conditions":"Helicobacter Pylori Infection","enrollment":782},{"nctId":"NCT06443502","phase":"PHASE3","title":"A Study to Learn About the Safety of Vedolizumab and How Well it Works in Children and Teenagers With Active Chronic Pouchitis","status":"RECRUITING","sponsor":"Takeda","startDate":"2024-11-19","conditions":"Pouchitis","enrollment":30},{"nctId":"NCT07146594","phase":"PHASE4","title":"Clinical Evaluation of a 14day Modified Bismuth Quadruple Therapy for the Eradication of Helicobacter Pylori in a High Clarithromycin and Metronidazole Resistance Area Regarding Patients With Peptic Ulcer and Non Ulcer Dyspepsia","status":"NOT_YET_RECRUITING","sponsor":"Athens Medical Center","startDate":"2025-08-20","conditions":"Helicobacter Pylori Gastritis, Helicobacter Eradication","enrollment":150},{"nctId":"NCT05977868","phase":"PHASE4","title":"Comparing Oral Versus Parenteral Antimicrobial Therapy","status":"TERMINATED","sponsor":"West Virginia University","startDate":"2023-08-04","conditions":"Endovascular Infection, Bone and Joint Infection, Skin and Soft Tissue Infection","enrollment":94},{"nctId":"NCT06131021","phase":"PHASE3","title":"Shaping the Indications for Periodontal Adjunctive Antibiotics in Dental Practice","status":"RECRUITING","sponsor":"Rutgers, The State University of New Jersey","startDate":"2024-04-25","conditions":"Periodontitis, Periodontal Diseases, Periodontal Pocket","enrollment":150},{"nctId":"NCT05608564","phase":"NA","title":"Local and Systemic Antimicrobials in Non-surgical Periodontal Therapy","status":"COMPLETED","sponsor":"University of Belgrade","startDate":"2023-01-17","conditions":"Periodontitis","enrollment":38},{"nctId":"NCT07021729","phase":"PHASE4","title":"Comparison of Two Treatment Regimens of Helicobacter Pylori Infection","status":"NOT_YET_RECRUITING","sponsor":"Rehman Medical Institute - RMI","startDate":"2025-12","conditions":"Helicobacter Pylori Infection","enrollment":156},{"nctId":"NCT03130452","phase":"PHASE4","title":"Helicobacter Pylori Eradication Study","status":"COMPLETED","sponsor":"Inje University","startDate":"2016-12-17","conditions":"Helicobacter Pylori Infection","enrollment":423},{"nctId":"NCT03897244","phase":"PHASE4","title":"Efficacies of HDDT With or Without Bismuth vs Amoxicillin-metronidazole BQT for First-line H Pylori Eradication","status":"COMPLETED","sponsor":"National Taiwan University Hospital","startDate":"2019-05-30","conditions":"Helicobacter Pylori Infection","enrollment":603},{"nctId":"NCT05934227","phase":"NA","title":"Amoxicillin Plus Metronidazole in Periodontal Maintenance","status":"COMPLETED","sponsor":"Federal University of Minas Gerais","startDate":"2023-07-01","conditions":"Periodontitis, Periodontal Pocket","enrollment":50},{"nctId":"NCT03365609","phase":"NA","title":"A Comparison of Four Different Treatment Regimens of Helicobacter Pylori in Chinese Children","status":"RECRUITING","sponsor":"Ying HUANG","startDate":"2017-09-20","conditions":"Helicobacter Infections","enrollment":1440},{"nctId":"NCT04140903","phase":"PHASE4","title":"Partial Oral Antibiotic Treatment for Bacterial Brain Abscess","status":"RECRUITING","sponsor":"Henrik Nielsen","startDate":"2020-11-06","conditions":"Brain Abscess, Cerebral Abscess","enrollment":400},{"nctId":"NCT06760065","phase":"PHASE3","title":"Comparison of Keverprazan Hydrochloride-Amoxicillin Dual Therapy and Susceptibility-Guided Quadruple Therapy for Helicobacter Pylori Rescue Treatment","status":"NOT_YET_RECRUITING","sponsor":"Sixth Affiliated Hospital, Sun Yat-sen University","startDate":"2025-01-15","conditions":"Helicobacter Pylori Infection Helicobacter Pylori Eradication Patient Education","enrollment":316},{"nctId":"NCT06561698","phase":"PHASE4","title":"High-dose Dual Therapy and Minocycline-cotaining Quadruple Therapy for Helicobacter Pylori Infection","status":"RECRUITING","sponsor":"Shanghai Jiao Tong University School of Medicine","startDate":"2024-08-21","conditions":"Helicobacter Pylori Infection","enrollment":200},{"nctId":"NCT06731023","phase":"","title":"Efficacy of a 14-Day Bismuth-Containing Quadruple Therapy Guided by Drug Susceptibility Testing in Patients with Extremely Refractory Helicobacter Pylori Infection: an Exploratory Study","status":"NOT_YET_RECRUITING","sponsor":"Xiuli Zuo","startDate":"2025-01-01","conditions":"HELICOBACTER PYLORI INFECTIONS","enrollment":30},{"nctId":"NCT06687473","phase":"PHASE4","title":"Susceptibility-guided Bismuth Quadruple Therapy for Multiple-resistant Helicobacter Pylori Strains","status":"COMPLETED","sponsor":"National Cheng-Kung University Hospital","startDate":"2022-01-01","conditions":"Helicobacter Pylori, Drug Resistance, Multiple, Virulence Factor","enrollment":13},{"nctId":"NCT06687499","phase":"PHASE4","title":"14-day Susceptibility-guided Bismuth Quadruple Therapy for Multiple Drug Resistant H. Pylori Infection","status":"COMPLETED","sponsor":"National Cheng-Kung University Hospital","startDate":"2022-08-22","conditions":"Helicobacter Pylori, Drug Resistance, Multiple","enrollment":46},{"nctId":"NCT05475431","phase":"","title":"Real-world Treatment of H. Pylori Eradication in Patients with Comorbidity","status":"COMPLETED","sponsor":"National Cheng-Kung University Hospital","startDate":"2020-05-06","conditions":"Helicobacter Pylori Infection, Comorbidities and Coexisting Conditions, Real-world Outcome","enrollment":1053},{"nctId":"NCT04803422","phase":"NA","title":"Per Oral Versus Intravenous Postoperative Antibiotics After Surgery for Complicated Appendicitis.","status":"COMPLETED","sponsor":"Zealand University Hospital","startDate":"2021-04-01","conditions":"Complicated Appendicitis","enrollment":3193},{"nctId":"NCT04755179","phase":"","title":"Identification of the Optimal Treatment Strategy for Complex Appendicitis in the Pediatric Population","status":"COMPLETED","sponsor":"Ramon Gorter","startDate":"2019-08-12","conditions":"Appendicitis, Appendix Mass, Appendicitis Perforated","enrollment":1308},{"nctId":"NCT05444218","phase":"NA","title":"Surgical Access Combined With Systematically Administered Antibiotics in the Treatment of Peri-implantitis","status":"COMPLETED","sponsor":"University of Guarulhos","startDate":"2021-05-01","conditions":"Peri-Implantitis","enrollment":89},{"nctId":"NCT04147065","phase":"PHASE4","title":"Helicobacter Pylori Eradication According to DPO-PCR Methods (K-CREATE) Study)","status":"RECRUITING","sponsor":"Incheon St.Mary's Hospital","startDate":"2021-07-14","conditions":"Helicobacter Pylori Infection","enrollment":1230},{"nctId":"NCT05681312","phase":"PHASE3","title":"Evaluation of the Effect of Systemic Proteolytic Enzyme Therapy on Postoperative Inflammatory Response and QoL After Surgical Extraction of Impacted Mandibular Third Molars","status":"RECRUITING","sponsor":"University of Baghdad","startDate":"2024-05-08","conditions":"Post Operative Pain","enrollment":55},{"nctId":"NCT04669717","phase":"PHASE4","title":"Antibiotics as Adjuncts to Periodontal Therapy:Pharmacokinetic Considerations and Dosing Strategies","status":"RECRUITING","sponsor":"University of Geneva, Switzerland","startDate":"2021-09-01","conditions":"Periodontal Diseases, Antibiotics, Pharmacokinetics","enrollment":45},{"nctId":"NCT06382493","phase":"NA","title":"Tegoprazan-containing Sequential for H. Pylori","status":"RECRUITING","sponsor":"Seoul National University Bundang Hospital","startDate":"2021-02-01","conditions":"Helicobacter Pylori Infection","enrollment":400},{"nctId":"NCT04149327","phase":"PHASE4","title":"Systemic Amoxicillin Plus Metronidazole in Peri-implantitis Treatment","status":"COMPLETED","sponsor":"University Medical Center Groningen","startDate":"2012-08-01","conditions":"Peri-implantitis, Periodontal Diseases","enrollment":62},{"nctId":"NCT05664685","phase":"PHASE4","title":"Optimized Bismuth Quadruple Therapy vs Triple Standard Therapy for Helicobacter Pylori Eradication","status":"COMPLETED","sponsor":"Pontificia Universidad Catolica de Chile","startDate":"2022-10-17","conditions":"Helicobacter Pylori Infection","enrollment":127},{"nctId":"NCT04573504","phase":"PHASE4","title":"Antibiotics for Severe Perineal Laceration to Prevent Infection Following Repair","status":"RECRUITING","sponsor":"Northwestern University","startDate":"2020-09-23","conditions":"Vaginal Laceration During Delivery","enrollment":274},{"nctId":"NCT06315478","phase":"PHASE4","title":"Safety and Efficacy of Triple and Quadruple Regimens as First Line Therapy for Management of Helicobacter Pylori Infection in Egyptians","status":"COMPLETED","sponsor":"Helwan University","startDate":"2021-02-01","conditions":"H.Pylori Infection","enrollment":60},{"nctId":"NCT01330719","phase":"NA","title":"Mechanisms and Treatment Response of Aggressive Periodontitis in Children","status":"COMPLETED","sponsor":"University of Florida","startDate":"2006-12","conditions":"Aggressive Periodontitis","enrollment":514},{"nctId":"NCT06275204","phase":"","title":"H. Pylori Screen-and-treat Study in a Population of Young Adults","status":"RECRUITING","sponsor":"University of Latvia","startDate":"2024-03-04","conditions":"Gastric Cancer, H Pylori Infection, H Pylori Eradication","enrollment":6800},{"nctId":"NCT06216639","phase":"","title":"Feasibility Study of the Proposed Test-and-treat Screening Program in Younger Participants With H. Pylori Infection","status":"UNKNOWN","sponsor":"National Institute of Public Health, Slovenia","startDate":"2024-02-01","conditions":"Helicobacter Pylori Infection","enrollment":2000},{"nctId":"NCT06177119","phase":"NA","title":"Amoxicillin and Metronidazole During or After the Periodontal Treatment","status":"UNKNOWN","sponsor":"Belén Retamal-Valdes","startDate":"2012-01-31","conditions":"Periodontitis","enrollment":72},{"nctId":"NCT03779074","phase":"PHASE3","title":"Comparing the Efficacy of Hybrid, High-dose Dual and Bismuth Quadruple Therapies","status":"COMPLETED","sponsor":"Kaohsiung Veterans General Hospital.","startDate":"2018-09-03","conditions":"Helicobacter Pylori Infection","enrollment":918},{"nctId":"NCT03779087","phase":"NA","title":"Efficacies of Two Bismuth Quadruple Therapies in the Second-line Treatment of H Pylori Infection","status":"COMPLETED","sponsor":"Ping-I (William) Hsu, M.D.","startDate":"2018-07-11","conditions":"Helicobacter Pylori Infection","enrollment":112},{"nctId":"NCT06065267","phase":"PHASE4","title":"Levofloxacin Concomitant Versus Levofloxacin Sequential","status":"NOT_YET_RECRUITING","sponsor":"Damascus Hospital","startDate":"2024-01-02","conditions":"Helicobacter Pylori Infection","enrollment":150},{"nctId":"NCT01273441","phase":"PHASE4","title":"Study Comparing Sequential and Concomitant Therapy for Helicobacter Pylori Eradication in Routine Clinical Practice","status":"COMPLETED","sponsor":"Fundación de Investigación Biomédica - Hospital Universitario de La Princesa","startDate":"2010-12","conditions":"Helicobacter Pylori","enrollment":338},{"nctId":"NCT04751500","phase":"NA","title":"The HYsteroscopic Miscarriage MaNagement Trial: A Pilot RCT Investigating a Novel Management Pathway for RPOC","status":"COMPLETED","sponsor":"Birmingham Women's and Children's NHS Foundation Trust","startDate":"2021-01-31","conditions":"Retained Products After Miscarriage","enrollment":149},{"nctId":"NCT04020458","phase":"NA","title":"Dental Intervention Plan for Chronic Kidney Disease Patients Awaiting or With Kidney Transplant","status":"TERMINATED","sponsor":"Augusta University","startDate":"2018-11-09","conditions":"Chronic Kidney Disease, Chronic Periodontitis, Generalized, Moderate","enrollment":11},{"nctId":"NCT05049902","phase":"PHASE4","title":"Bismuth-containing Quadruple Therapy for Helicobacter Pylori Eradication","status":"COMPLETED","sponsor":"Shandong University","startDate":"2021-09-21","conditions":"Helicobacter Pylori Infection","enrollment":1300},{"nctId":"NCT05850117","phase":"NA","title":"Efficacies of Tetracycline-levofloxacin, Standard Bismuth, Amoxicillin-levofloxacin Quadruple Therapy for H.p","status":"UNKNOWN","sponsor":"Kaohsiung Medical University","startDate":"2020-02-10","conditions":"Helicobacter Pylori Eradication","enrollment":240},{"nctId":"NCT05164887","phase":"","title":"Microbiota Implementation to Reduce Anastomotic Colorectal Leaks (MIRACLe)","status":"COMPLETED","sponsor":"S.Eugenio Hospital","startDate":"2020-12-01","conditions":"Colorectal Cancer, Surgery, LAP","enrollment":131},{"nctId":"NCT02373280","phase":"NA","title":"The Efficacy of the 7 Days Tailored Therapy as the 1st Eradication of H. Pylori Infection","status":"UNKNOWN","sponsor":"Seoul National University Bundang Hospital","startDate":"2014-08","conditions":"Helicobacter Infection","enrollment":600},{"nctId":"NCT02359331","phase":"NA","title":"The Efficacy of the 7 Days Tailored Therapy as 2nd Rescue Therapy for Eradication of H. Pylori Infection","status":"TERMINATED","sponsor":"Seoul National University Bundang Hospital","startDate":"2014-08","conditions":"Helicobacter Infection","enrollment":370},{"nctId":"NCT05669651","phase":"NA","title":"Explore the Efficacy and Safety of FMT With Different Bacterial Doses in the Treatment of Hepatic Encephalopathy","status":"UNKNOWN","sponsor":"Hainv Gao","startDate":"2022-12-01","conditions":"Hepatic Encephalopathy","enrollment":100},{"nctId":"NCT05726734","phase":"PHASE4","title":"Vonoprazan-containing Triple Therapy Versus Empiric Bismuth Quadruple Therapy for First-line Helicobacter Pylori Treatment: a Randomized Clinical Trial","status":"UNKNOWN","sponsor":"Shanghai East Hospital","startDate":"2023-02-06","conditions":"Helicobacter Pylori Infection","enrollment":100},{"nctId":"NCT04660123","phase":"PHASE4","title":"A Real World Study of Bismuth Colloidal Pectin Granules Quadruple Therapy for H. Pylori Eradication","status":"COMPLETED","sponsor":"Xijing Hospital of Digestive Diseases","startDate":"2020-12-20","conditions":"Gastric Cancer, Helicobacter Pylori Infection, Bismuth","enrollment":959},{"nctId":"NCT04853875","phase":"PHASE4","title":"ILTHPI - Comparison of Medicament Containing Tetracycline, Metronidazole, Bismuth Versus Amoxicillin, Metronidazole, Clarithromycin","status":"COMPLETED","sponsor":"Mackay Memorial Hospital","startDate":"2021-04-19","conditions":"Helicobacter Pylori Infection","enrollment":104},{"nctId":"NCT05115201","phase":"NA","title":"Effect of Antibiotics on Systemic Inflammation","status":"COMPLETED","sponsor":"Postgraduate Institute of Dental Sciences Rohtak","startDate":"2021-11-26","conditions":"Periodontitis","enrollment":41},{"nctId":"NCT05655338","phase":"NA","title":"Antimicrobial Photodynamic Therapy in Treatment of Aggressive Periodontitis (Stage III, Grade C Periodontitis)","status":"COMPLETED","sponsor":"University of Ljubljana","startDate":"2015-01-10","conditions":"Aggressive Periodontitis","enrollment":20},{"nctId":"NCT05635942","phase":"PHASE4","title":"Optimized-dose Amoxicillin Versus Standard-dose Amoxicillin for Quadruple Therapy in Helicobacter Pylori Eradication","status":"COMPLETED","sponsor":"Les Laboratoires des Médicaments Stériles","startDate":"2019-01-29","conditions":"Helicobacter Pylori","enrollment":88},{"nctId":"NCT02185209","phase":"PHASE4","title":"Surgical Treatment of Peri-implantitis With and Without Systemically Adjunctive Antibiotics","status":"COMPLETED","sponsor":"Margareta Hultin","startDate":"2015-03","conditions":"Periodontal Diseases, Periimplantitis","enrollment":77},{"nctId":"NCT03163602","phase":"NA","title":"Surgical Treatment of Peri-implantitis","status":"COMPLETED","sponsor":"The University of Western Australia","startDate":"2017-05-15","conditions":"Peri-Implantitis","enrollment":40},{"nctId":"NCT05152004","phase":"NA","title":"Efficacies of Hybrid and High-dose Dual Therapies for the First-line Anti-H Pylori Treatment","status":"COMPLETED","sponsor":"Chang Gung Memorial Hospital","startDate":"2018-09-01","conditions":"Helicobacter Pylori Infection","enrollment":240},{"nctId":"NCT05449028","phase":"NA","title":"Helicobacter Pylori Eradication Therapy in Portugal","status":"UNKNOWN","sponsor":"Unidade Local de Saúde de Coimbra, EPE","startDate":"2022-05-01","conditions":"Helicobacter Pylori, Gut Microbiota, Immunology","enrollment":230},{"nctId":"NCT03148366","phase":"PHASE3","title":"Comparison of the Levofloxacin Sequential Therapy and Quadruple Therapy in Second Line Treatment for HP","status":"COMPLETED","sponsor":"National Taiwan University Hospital","startDate":"2015-02","conditions":"Helicobacter","enrollment":560},{"nctId":"NCT03986996","phase":"PHASE2","title":"Antimicrobial Therapy for Ulcerative Colitis (UC)","status":"TERMINATED","sponsor":"Wolfson Medical Center","startDate":"2019-07-25","conditions":"Ulcerative Colitis","enrollment":20},{"nctId":"NCT02345733","phase":"PHASE4","title":"Use of a Novel Diet (UC DIET) for Treatment of Mild to Moderate Active Pediatric Ulcerative Colitis","status":"COMPLETED","sponsor":"Prof. Arie Levine","startDate":"2015-09-01","conditions":"Ulcerative Colitis (UC)","enrollment":20},{"nctId":"NCT04178187","phase":"NA","title":"The Role of Probiotics in the Eradication of Helicobacter Pylori","status":"COMPLETED","sponsor":"Evangelismos Hospital","startDate":"2019-10-02","conditions":"Helicobacter Pylori Infection","enrollment":660},{"nctId":"NCT05293977","phase":"NA","title":"Short-Term Use of Antibiotics and Adherence Level","status":"COMPLETED","sponsor":"Jordan University of Science and Technology","startDate":"2020-08-03","conditions":"Acute Infection","enrollment":589},{"nctId":"NCT05250050","phase":"PHASE4","title":"Susceptibility-Guided Therapy for Helicobacter Pylori Infection Treatment","status":"UNKNOWN","sponsor":"Shanghai Zhongshan Hospital","startDate":"2022-03-25","conditions":"Helicobacter Pylori Infection","enrollment":388},{"nctId":"NCT04748120","phase":"NA","title":"Operative vs Non-Operative Management of Acute Appendicitis and Acute Cholecystitis in COVID-19 Positive Patients","status":"TERMINATED","sponsor":"The Cleveland Clinic","startDate":"2020-12-28","conditions":"Covid19, Appendicitis, Cholecystitis, Acute","enrollment":2},{"nctId":"NCT05002595","phase":"","title":"H. Pylori Treatment Between Modified Quadruple Regimen and Tailored Therapy","status":"COMPLETED","sponsor":"Soonchunhyang University Hospital","startDate":"2018-01-01","conditions":"H. Pylori Infection","enrollment":270},{"nctId":"NCT05191888","phase":"PHASE4","title":"14-day PCAB-based High-dose Dual Therapy and14-day PCAB-based Triple Therapy vs 14-day PPI-based Reverse Hybrid Therapy","status":"UNKNOWN","sponsor":"Kaohsiung Medical University","startDate":"2021-08-06","conditions":"Helicobacter Pylori Eradication","enrollment":906},{"nctId":"NCT02969928","phase":"PHASE2, PHASE3","title":"Two Different Antibiotic Agents to Treat Generalized Aggressive Periodontitis","status":"COMPLETED","sponsor":"Universidade Estadual Paulista Júlio de Mesquita Filho","startDate":"2015-03","conditions":"Aggressive Periodontitis","enrollment":46},{"nctId":"NCT05126121","phase":"NA","title":"Efficacy and Safety of 14-day Concomitant Therapy for Difficult-to-Treat Helicobacter Pylori Infection","status":"UNKNOWN","sponsor":"Xiuli Zuo","startDate":"2021-11-20","conditions":"Helicobacter Pylori Infection","enrollment":60},{"nctId":"NCT05133193","phase":"NA","title":"Efficacy and Safety of 14-day Concomitant Therapy for Refractory Helicobacter Pylori Infection","status":"UNKNOWN","sponsor":"Shandong University","startDate":"2021-11-20","conditions":"Helicobacter Pylori Infection","enrollment":60},{"nctId":"NCT02033408","phase":"NA","title":"Manipulating the Microbiome in IBD by Antibiotics and FMT","status":"COMPLETED","sponsor":"Shaare Zedek Medical Center","startDate":"2014-01","conditions":"Exacerbation of Ulcerative Colitis, Ulcerative Colitis, Active Severe, Crohn's Colitis","enrollment":28},{"nctId":"NCT05061732","phase":"PHASE4","title":"Helicobacter Pylori Eradication and Follow-up","status":"RECRUITING","sponsor":"Shanghai Zhongshan Hospital","startDate":"2021-09-30","conditions":"Helicobacter Pylori Infection","enrollment":4447},{"nctId":"NCT04024527","phase":"PHASE4","title":"High Dose of Dual Therapy Plus Metronidazole for Helicobacter Pylori RescueTreatment","status":"COMPLETED","sponsor":"Shanghai Jiao Tong University School of Medicine","startDate":"2019-07-25","conditions":"Helicobacter Pylori Infection","enrollment":306},{"nctId":"NCT03592069","phase":"PHASE4","title":"Concomitant Versus Hybrid Regimen for H. Pylori Eradication","status":"COMPLETED","sponsor":"Alexandra Hospital, Athens, Greece","startDate":"2018-02-21","conditions":"H.Pylori Infection, H.Pylori Gastrointestinal Disease, H. Pylori Associated Phlegmonous Gastritis","enrollment":345},{"nctId":"NCT05014685","phase":"PHASE4","title":"PPI-amoxicillin for H. Pylori Treatment","status":"UNKNOWN","sponsor":"Shanghai Zhongshan Hospital","startDate":"2021-08-20","conditions":"Helicobacter Pylori Infection","enrollment":732},{"nctId":"NCT04580355","phase":"PHASE4","title":"Impact of Non-surgical Periodontal Therapy on Oral and Gut Microbiome","status":"UNKNOWN","sponsor":"University of Campinas, Brazil","startDate":"2021-07","conditions":"Microbial Colonization, Periodontal Diseases, Periodontal Inflammation","enrollment":30},{"nctId":"NCT04901117","phase":"PHASE4","title":"Bismuth-containing Quadruple Therapy for Helicobacter Pylori Eradication: A Randomized Clinical Trial of 10 and 14 Days","status":"UNKNOWN","sponsor":"Shandong University","startDate":"2021-06","conditions":"Helicobacter Pylori Infection","enrollment":1300},{"nctId":"NCT03383120","phase":"NA","title":"Diode Laser for Treatment of Peri-implantitis","status":"COMPLETED","sponsor":"University of Geneva, Switzerland","startDate":"2017-10-10","conditions":"Peri-Implantitis, Implant Complication","enrollment":40},{"nctId":"NCT02099240","phase":"EARLY_PHASE1","title":"Patients Response to Early Switch To Oral:Osteomyelitis Study","status":"TERMINATED","sponsor":"Julio Ramirez","startDate":"2014-03-06","conditions":"Osteomyelitis","enrollment":11},{"nctId":"NCT04769583","phase":"PHASE4","title":"14-day Quadruple Therapy Versus Triple Therapy in HP Eradication","status":"COMPLETED","sponsor":"mohamed bouchoucha","startDate":"2019-02-10","conditions":"Gastritis H Pylori","enrollment":121},{"nctId":"NCT03572777","phase":"NA","title":"Comparison of Therapy in Treatment of Patients With Helicobacter Pylori Infection: Concomitant Versus Hybrid Therapy.","status":"COMPLETED","sponsor":"Antonio Mestrovic","startDate":"2018-04-15","conditions":"Helicobacter Pylori Infection","enrollment":159},{"nctId":"NCT04721704","phase":"NA","title":"Comparison of Efficacy of Triple Regimen Based on Clarithromycin VS Metronidazole in Children","status":"UNKNOWN","sponsor":"Shaheed Zulfiqar Ali Bhutto Medical University","startDate":"2020-09-14","conditions":"H Pylori Gastritis","enrollment":36},{"nctId":"NCT04107194","phase":"PHASE3","title":"Non-invasive Test-guided Tailored Therapy Versus Empiric Treatment for Helicobacter Pylori Infection.","status":"UNKNOWN","sponsor":"University of Bari","startDate":"2020-01-14","conditions":"Helicobacter Pylori Infection, Antibiotic Resistant Infection, Antibiotic Resistant Strain","enrollment":362},{"nctId":"NCT04667299","phase":"PHASE4","title":"Bismuth-Metronidazole Triple Therapy for H. Pylori First-line Treatment","status":"UNKNOWN","sponsor":"Shanghai Zhongshan Hospital","startDate":"2020-12-20","conditions":"Helicobacter Pylori Infection","enrollment":270},{"nctId":"NCT02646332","phase":"NA","title":"Comparing the Efficacy of Reverse Hybrid Therapy and Concomitant Therapy","status":"COMPLETED","sponsor":"Kaohsiung Veterans General Hospital.","startDate":"2015-12","conditions":"Helicobacter Pylori Infection","enrollment":248}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":359,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Flagyl® 400 Filmtablette","Amoxicillin-ratiopharm® 500"],"phase":"marketed","status":"active","brandName":"amoxicillin and metronidazole","genericName":"amoxicillin and metronidazole","companyName":"University of Campinas, Brazil","companyId":"university-of-campinas-brazil","modality":"Small molecule","firstApprovalDate":"","aiSummary":"This combination uses amoxicillin to inhibit bacterial cell wall synthesis and metronidazole to disrupt anaerobic bacterial DNA, providing broad-spectrum coverage against aerobic and anaerobic pathogens. Used for Mixed aerobic-anaerobic bacterial infections, Helicobacter pylori eradication (as part of triple or quadruple therapy), Periodontal infections.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}